The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response

Simultaneous assessment of immunohistochemistry, in vivo tumour properties and gene expression profiling in a comprehensive set of xenograft models can be used to validate and potentially infer biological information about prognostic gene signatures.